Total Payments
$2,684
2024 Payments
$243.20
Companies
22
Transactions
142
Medicare Patients
4,360
Medicare Billing
$606,707
Payment Breakdown by Category
Food & Beverage$2,649 (98.7%)
Education$34.95 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,649 | 141 | 98.7% |
| Education | $34.95 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $563.46 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $301.86 | 16 | $0 (2024) |
| GENZYME CORPORATION | $301.82 | 15 | $0 (2023) |
| PFIZER INC. | $261.54 | 13 | $0 (2023) |
| Genentech USA, Inc. | $206.75 | 16 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $195.77 | 10 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $156.63 | 10 | $0 (2020) |
| Puma Biotechnology, Inc. | $125.00 | 1 | $0 (2019) |
| BioCryst US Sales Co., LLC | $89.81 | 4 | $0 (2023) |
| kaleo, Inc. | $79.67 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $243.20 | 11 | GlaxoSmithKline, LLC. ($106.72) |
| 2023 | $464.01 | 22 | AstraZeneca Pharmaceuticals LP ($93.64) |
| 2022 | $416.61 | 26 | Genentech USA, Inc. ($120.78) |
| 2021 | $234.61 | 14 | GlaxoSmithKline, LLC. ($58.35) |
| 2020 | $277.33 | 15 | GlaxoSmithKline, LLC. ($87.95) |
| 2019 | $400.39 | 17 | Puma Biotechnology, Inc. ($125.00) |
| 2018 | $242.45 | 14 | GlaxoSmithKline, LLC. ($80.68) |
| 2017 | $405.84 | 23 | Teva Pharmaceuticals USA, Inc. ($87.76) |
All Payment Transactions
142 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Respiratory | ||||||
| 05/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: IMMUNOLOGY | ||||||
| 04/09/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Inflammation | ||||||
| 02/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: IMMUNOLOGY | ||||||
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: Respiratory | ||||||
| 02/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $30.68 | General |
| Category: RESPIRATORY | ||||||
| 02/13/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $22.98 | General |
| Category: Oncology / Rare Diseases | ||||||
| 01/16/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Respiratory | ||||||
| 12/19/2023 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $36.89 | General |
| Category: Allergy | ||||||
| 12/05/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Immunology | ||||||
| 11/30/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/28/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Respiratory | ||||||
| 11/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: GENETIC DISEASE | ||||||
| 10/31/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/24/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/26/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.69 | General |
| Category: Dermatology | ||||||
| 07/19/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Respiratory | ||||||
| 07/13/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/06/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Respiratory | ||||||
| 06/23/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,204 | 13,369 | $329,407 | $147,683 |
| 2022 | 16 | 1,177 | 14,651 | $384,777 | $194,486 |
| 2021 | 13 | 1,046 | 13,046 | $290,054 | $137,928 |
| 2020 | 13 | 933 | 13,147 | $287,661 | $126,610 |
Total Patients
4,360
Total Services
54,213
Medicare Billing
$606,707
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 369 | 6,194 | $136,268 | $71,783 | 52.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 185 | 275 | $50,875 | $24,008 | 47.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 84 | 3,992 | $43,912 | $12,603 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 104 | 104 | $28,600 | $12,142 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 84 | $10,500 | $5,077 | 48.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 33 | $8,085 | $4,511 | 55.8% |
| 95044 | Test for allergy using skin patch | Office | 2023 | 13 | 1,117 | $12,287 | $4,222 | 34.4% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 46 | 499 | $12,475 | $3,974 | 31.9% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 51 | 559 | $11,180 | $3,956 | 35.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 95 | 136 | $8,568 | $2,658 | 31.0% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 42 | 47 | $3,196 | $1,284 | 40.2% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 19 | 192 | $2,639 | $1,205 | 45.7% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 94 | 137 | $822.00 | $260.91 | 31.7% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 325 | 5,556 | $122,232 | $66,622 | 54.5% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 11 | 1,950 | $89,700 | $58,363 | 65.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 132 | $24,420 | $12,365 | 50.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 164 | 196 | $24,500 | $11,524 | 47.0% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 80 | 3,509 | $38,599 | $11,409 | 29.6% |
| 95044 | Test for allergy using skin patch | Office | 2022 | 27 | 1,967 | $21,637 | $7,885 | 36.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 75 | 75 | $13,500 | $6,185 | 45.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $9,075 | $4,104 | 45.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 11 | 67 | $9,045 | $4,073 | 45.0% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 55 | 424 | $10,600 | $3,216 | 30.3% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 43 | 335 | $6,700 | $2,365 | 35.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 15 | $3,675 | $2,197 | 59.8% |
About Dr. Mark Ebadi, MD
Dr. Mark Ebadi, MD is a Specialist healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639140247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Ebadi, MD has received a total of $2,684 in payments from pharmaceutical and medical device companies, with $243.20 received in 2024. These payments were reported across 142 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,649).
As a Medicare-enrolled provider, Ebadi has provided services to 4,360 Medicare beneficiaries, totaling 54,213 services with total Medicare billing of $606,707. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Denver, CO
- Active Since 01/31/2006
- Last Updated 12/19/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1639140247
Products in Payments
- NUCALA (Biological) $402.64
- DUPIXENT (Biological) $341.65
- Xolair (Biological) $174.93
- EUCRISA (Drug) $156.03
- Nerlynx (Drug) $125.00
- FASENRA (Biological) $123.54
- DUPIXENT (Drug) $90.71
- BREO (Drug) $88.89
- AUVI-Q (Drug) $79.67
- TAKHZYRO (Biological) $72.81
- TEZSPIRE (Biological) $72.26
- ORLADEYO (Drug) $71.03
- CINQAIR (Drug) $66.89
- DUPIXENT DUPILUMAB INJECTION (Biological) $65.23
- QVAR (Drug) $59.97
- TRELEGY ELLIPTA (Drug) $57.23
- BREZTRI (Drug) $55.69
- FASENRA (Drug) $42.60
- Xhance (Drug) $40.00
- RUCONEST (Biological) $39.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Denver
Dr. Raymond Kim, Md, MD
Specialist — Payments: $3.7M
Specialist $3.7M
Dr. Anthony Canfield, M.d, M.D
Specialist — Payments: $953,125
Specialist $953,125
Dr. James Chappell, Md, MD
Specialist — Payments: $538,342
Specialist $538,342
Dr. Barbara Schwartzberg, M.d, M.D
Specialist — Payments: $447,617
Specialist $447,617
Dr. Giancarlo Barolat-Romana, Md, MD
Specialist — Payments: $328,167
Specialist $328,167
Michael Schiff, M.d, M.D
Specialist — Payments: $244,233
Specialist $244,233